業績

2025年

原著

1. Keisuke Suzuki, Shiho Suzuki, Hiroaki Fujita, Saro Kobayashi, Mukuto Shioda, Ryotaro Hida, Koichi Hirata : The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine. J Headache Pain 26(1): 36, 2025. [PMID: 39972460]
2. Daisuke Danno, Shiho Suzuki, Tsubasa Takizawa, Ryotaro Ishii, Masayuki Hamakawa, Yoshinori Tanizawa, Satoshi Osaga, Mika Komori : The Impact of Migraine on the Whole Life Course of Patients: Results from the OVERCOME (Japan) 2nd Study. Neurol Ther 14(1): 335-356, 2025. [PMID: 39708221]
3. Hiroshi Nagayama, Osamu Kano, Renpei Sengoku, Naotake Yanagisawa, Asako Yoritaka, Keisuke Suzuki, Noriko Nishikawa, Yohei Mukai, Kyoichi Nomura, Norihito Yoshida, Morinobu Seki, Miho Kawabe Matsukawa, Hiroo Terashi, Katsuo Kimura, Jun Tashiro, Shigeki Hirano, Hidetomo Murakami, Hideto Joki, Tsuyoshi Uchiyama, Hideki Shimura, Kotaro Ogaki, Jiro Fukae, Yoshio Tsuboi, Kazushi Takahashi, Toshimasa Yamamoto, Kenichi Kaida, Ryoko Ihara, Kazutomi Kanemaru, Taku Hatano : Impact of istradefylline on motor and non-motor symptoms in patients with Parkinson's disease: Subanalysis of the ISTRA ADJUST PD. Clin Park Relat Disord. 2025 Apr 17:12:100327. doi: 10.1016/j.prdoa.2025.100327. eCollection 2025. [PMID: 40321705]
4. Naoko Matsui, Keiko Tanaka, Norito Kokubun, Yuki Hatanaka, Mitsuyo Ishida, Yusuke Osaki, Takeshi Watanabe, Osamu Watanabe, Eiji Matsuura, Hiroshi Takashima, Yasunori Sato, Satoshi Kuwabara, Yuishin Izumi; Japanese Isaacs study group : Prevalence, clinical profiles, and prognosis of Isaacs syndrome: A nationwide survey study in Japan. J Neurol Sci. 2025 May 15:472:123442. doi: 10.1016/j.jns.2025.123442. Epub 2025 Feb 25. [PMID: 40058033]
5. Kazuo Fujihara, Noriko Isobe, Katsuichi Miyamoto, Masaaki Niino, Jin Nakahara, Satoshi Hattori, Mamoru Yamamoto, Izumi Kawachi, Naoko Matsui, Chiyoko Nohara, Norito Kokubun, Norio Chihara, Tatsuro Misu, Kazumasa Okada, Katsuhisa Yamashita, Tadashi Nagatsuka, Hiroki Adachi, Ichiro Nakashima : Effectiveness of satralizumab in a real-world clinical setting in Japan: Interleukin-6 receptor inhibition in neuromyelitis optica spectrum disorder: A six-month interim analysis of a multicenter medical chart review. Mult Scler Relat Disord. 2025 Mar 19:98:106384. doi: 10.1016/j.msard.2025.106384. Online ahead of print. [PMID: 40203604]
6. Ryotaro Ishii, Tsubasa Takizawa, Shiho Suzuki, Daisuke Danno, Moemi Miura, Yoshinori Tanizawa, Satoshi Osaga, Chie Hashimoto, Mika Komori : Real-world use of over-the-counter medications by patients with migraine in Japan: results from the OVERCOME (Japan) 2nd study. J Headache Pain. 2025 May 7;26(1):107. doi: 10.1186/s10194-025-02046-8. [PMID: 40335927]
7. 竹川英宏, 宮脇郁子, 福本義弘, 益子貴史, 角田亘, 牧田茂, 藤本茂：一次脳卒中センターにおける複合疾患を有する脳卒中患者に対するリハビリテーションの現状．脳卒中 47(1): 7-16, 2025.

Editorial

1. Keisuke Suzuki : Relationship between low back pain and sleep quality. Sleep Biol. Rhythms(2025). https://doi.org/10.1007/s41105-025-00589-6

総説

1. Keisuke Suzuki, Hiroaki Fujita, Saro Kobayashi : Managing sleep issues in Parkinson's disease: an up-to-date review. Expert Rev Neurother 25(2): 211-226, 2025. [PMID: 39789992]
2. 鈴木圭輔，藤田裕明：Digestシリーズ　睡眠科学の進歩(Vol.4)　レム睡眠行動異常症とαシヌクレイノパチー．Medical Science Digest 51(1): 3-5, 2025.
3. 鈴木圭輔，藤田裕明，櫻本浩隆：パーキンソン病における睡眠障害とその治療．日本医師会雑誌 153(12): 1289-1293, 2025.
4. 国分則人：【CIDP 50年】CIDPの治療　3つのmainstay治療をどのように組み立てるか．BRAIN and NERVE: 神経研究の進歩 77(1): 43-48, 2025.
5. 鈴木紫布，鈴木圭輔：【頭痛からみえる疾患-QOLの改善にむけて】片頭痛の疫学と社会負担．カレントテラピー 43(1): 8-13, 2025.
6. 駒ヶ嶺朋子，園生雅弘：「機能性（functional）」の対義語としての用語「器質性」について．臨床神経 65(4): 2025. https://doi.org/10.5692/clinicalneurol.cn-002065